Myeloid precursor cell useful for gene therapy and for modulation of immune responses
View Patent ↗A long-lived, myeloid-committed stem cell population is disclosed. Also disclosed are methods and compositions for targeting this population with retrovirus vectors in gene therapy protocols for correcting congenital disorders of myeloid system and for potentiating immune responses to defined tumor and viral antigens.
1. A method for expressing exogenous nucleic acids in myeloid-committed stem cells comprising:
a) obtaining myeloid-committed stem cells from spleen; and
b) contacting said cells with a retroviral vector containing at least one nucleic acid encoding a myeloid specific protein, under conditions whereby said vector enters cells and expresses a protein encoded by said at least one nucleic acid.
2. A method as claimed in claim 1 , wherein said at least one nucleic acid encoding a myeloid specific protein is operably linked to a myeloid cell specific promoter.